Lukas Graf

1.9k total citations
79 papers, 1.3k citations indexed

About

Lukas Graf is a scholar working on Hematology, Internal Medicine and Surgery. According to data from OpenAlex, Lukas Graf has authored 79 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 16 papers in Internal Medicine and 14 papers in Surgery. Recurrent topics in Lukas Graf's work include Platelet Disorders and Treatments (18 papers), Venous Thromboembolism Diagnosis and Management (16 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (9 papers). Lukas Graf is often cited by papers focused on Platelet Disorders and Treatments (18 papers), Venous Thromboembolism Diagnosis and Management (16 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (9 papers). Lukas Graf collaborates with scholars based in Switzerland, United States and Germany. Lukas Graf's co-authors include J. Yariv, Maurice M. Rapport, Philip E. Duffy, Catherine P.M. Hayward, J M Pesando, Karen A. Moffat, Wolfgang Korte, Jan–Dirk Studt, Dimitrios A. Tsakiris and Michael Nagler and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Lukas Graf

73 papers receiving 1.2k citations

Peers

Lukas Graf
Weiyi Liu China
John C. Kermode United States
A. Maria Olofsson United States
Andrea Wilke Germany
R. Hofbauer Austria
Dhanendra Tomar United States
Lukas Graf
Citations per year, relative to Lukas Graf Lukas Graf (= 1×) peers Zhenghui Liu

Countries citing papers authored by Lukas Graf

Since Specialization
Citations

This map shows the geographic impact of Lukas Graf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Graf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Graf more than expected).

Fields of papers citing papers by Lukas Graf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukas Graf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Graf. The network helps show where Lukas Graf may publish in the future.

Co-authorship network of co-authors of Lukas Graf

This figure shows the co-authorship network connecting the top 25 collaborators of Lukas Graf. A scholar is included among the top collaborators of Lukas Graf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukas Graf. Lukas Graf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamzeh‐Cognasse, Hind, Janna Hastings, Jan–Dirk Studt, et al.. (2024). Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia. Blood Advances. 8(11). 2825–2834. 5 indexed citations
2.
Larsen, Emil List, Jan–Dirk Studt, Dimitrios A. Tsakiris, et al.. (2024). Accuracy of Diagnosing Heparin-Induced Thrombocytopenia. JAMA Network Open. 7(3). e243786–e243786. 6 indexed citations
3.
Volken, Thomas, Sergio Cogliatti, Thomas Lehmann, et al.. (2023). CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70—A Retrospective Study. Cancers. 15(5). 1479–1479. 2 indexed citations
4.
Volken, Thomas, Sergio Cogliatti, Thomas Lehmann, et al.. (2023). Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study. Cancers. 15(19). 4698–4698. 1 indexed citations
5.
Graf, Lukas, et al.. (2023). Human blood-labyrinth barrier on a chip: a unique in vitro tool for investigation of BLB properties. RSC Advances. 13(36). 25508–25517. 8 indexed citations
6.
Studt, Jan–Dirk, Lorenzo Alberio, Pierre Fontana, et al.. (2023). Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban Calibrator. Diagnostics. 13(12). 2128–2128. 1 indexed citations
7.
Cuker, Adam, S. Haug, Christos T. Nakas, et al.. (2022). A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: a prospective, multicenter, observational study. EClinicalMedicine. 55. 101745–101745. 21 indexed citations
8.
Studt, Jan–Dirk, Lorenzo Alberio, Pierre Fontana, et al.. (2022). Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study. Frontiers in Cardiovascular Medicine. 9. 817826–817826. 10 indexed citations
9.
Rösslein, Matthias, Oliver Nolte, Peter Wick, et al.. (2022). Mild COVID-19 induces early, quantifiable, persistent troponin I elevations in elder men. Frontiers in Cardiovascular Medicine. 9. 1053790–1053790. 4 indexed citations
10.
Casini, Alessandro, Lorenzo Alberio, Anne Angelillo‐Scherrer, et al.. (2020). Thromboprophylaxis and laboratory monitoring for in-hospital patients with Covid-19 - a Swiss consensus statement by the Working Party Hemostasis. Swiss Medical Weekly. 150. w20247–w20247. 69 indexed citations
11.
Kägi, Georg, et al.. (2020). Stroke in a young adult with mild COVID-19 suggesting endotheliitis. New Microbes and New Infections. 38. 100781–100781. 13 indexed citations
12.
Fontana, Pierre, Lorenzo Alberio, Manuela Albisetti, et al.. (2020). Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab. Swiss Medical Weekly. 150(5153). w20422–w20422. 14 indexed citations
13.
Chong, Michael, Subia Tasneem, Lukas Graf, et al.. (2020). Bleeding risks for uncharacterized platelet function disorders. Research and Practice in Thrombosis and Haemostasis. 4(5). 799–806. 11 indexed citations
14.
Graf, Lukas. (2018). Extended Half-Life Factor VIII and Factor IX Preparations. Transfusion Medicine and Hemotherapy. 45(2). 86–91. 49 indexed citations
15.
Graf, Lukas & Dimitrios A. Tsakiris. (2012). Anticoagulant treatment: the end of the old agents?. Swiss Medical Weekly. 142(3940). w13684–w13684. 7 indexed citations
16.
Medinger, Michael, Elisabeth Saller, Cornelis L. Harteveld, et al.. (2011). A Rare Case of Coinheritance of Hemoglobin H Disease and Sickle Cell Trait Combined with Severe Iron Deficiency. SHILAP Revista de lepidopterología. 3(3). e30–e30. 2 indexed citations
17.
Graf, Lukas & M. Stern. (2011). Acute phase after haematopoietic stem cell transplantation. Hämostaseologie. 32(1). 56–62. 15 indexed citations
18.
Graf, Lukas, et al.. (2005). Impact of aspirate smears and trephine biopsies in routine bone marrow diagnostics: a comparative study of 141 cases. Swiss Medical Weekly. 135(910). 151–151. 9 indexed citations
19.
Martínez, Fernando J., Jonathan B. Orens, Richard I. Whyte, et al.. (1996). Lung Mechanics and Dyspnea After Lung Transplantation for Chronic Airflow Obstruction. American Journal of Respiratory and Critical Care Medicine. 153(5). 1536–1543. 26 indexed citations
20.
Graf, Lukas. (1976). Isolation and evolution of the gastrointestinal hormones.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 47(4). 285–98. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026